Synthesis of specialty compounds
Ended Purchase Order Awarded
- Contract number
- 75N92022P00256
- Awardee
-
American Biochemicals Inc. UEI M8PXMXZ1G2E5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $32,450
Award facts
- Opportunity
-
- Synthesis of Specialty Compounds Solicitation · 75N92022Q0404 · Posted Jul 20, 2022
- Contract value 100% obligated
- $32,450.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- College Station, TX 77840, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N92022P00256?
75N92022P00256 was awarded to American Biochemicals Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 9, 2022.
How much is contract 75N92022P00256 worth?
The government has obligated $32,450 on 75N92022P00256.
Was contract 75N92022P00256 competed?
The extent of competition for 75N92022P00256 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award